AF
INDV icon

Allworth Financial’s Indivior Pharmaceuticals INDV Stock Holding History

Allworth Financial’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19K Buy
463
+66
+17% +$2.39K ﹤0.01% 3241
2026
Q1 		$12.1K Buy
397
+10
+3% +$330 ﹤0.01% 3376
2025
Q4 		$13.9K Buy
387
+358
+1,234% +$10.9K ﹤0.01% 3035
2025
Q3 		$700 Buy
+29
New +$607 ﹤0.01% 4355

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allworth Financial's INDV Position: Q2 2026 in Review

Allworth Financial increased its Indivior Pharmaceuticals (INDV) stake by 17% in Q2 2026, buying an estimated $2.39K and bringing the position to 463 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #3241.

Allworth Financial first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Allworth Financial held 463 shares of Indivior Pharmaceuticals worth $19K as of Q2 2026.
  • Allworth Financial bought 66 Indivior Pharmaceuticals shares in Q2 2026, an estimated $2.39K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3241 holding.
  • Allworth Financial first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.